Yes, I would think things will heat up by the BIO Conference. Keep in mind, ADA starts next Friday. If the stars align, I would expect Urano's publications to be released just around that time. What better way to bust on the Diabetes/Wolframs scene but right around ADA? I think Lympro partner and data can get us easily past 0.50. A MANF partner or just really good data could push it toward a dollar or more. Anything above .50 for an uplist would be fine with me too, but the higher the better.